<DOC>
	<DOCNO>NCT03088137</DOCNO>
	<brief_summary>The purpose study show equivalence regard number oocyte retrieve follitropin alfa ( pen-injectors ) Primapur® Gonal-f® woman undergo IVF/ICSI</brief_summary>
	<brief_title>Study Compare Efficacy Safety Primapur Gonal-f Women Assisted Reproductive Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Female</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Infertility due tubal factor and/or male factor Age 20 35 year regular menstrual cycle 2135 day First second cycle present series ART BMI ≥ 18 ≤ 30 kg/m2 Basal FSH &lt; 10 IU/L ( cycle day 25 ) E2 level &lt; 50pg/mL ( cycle day 2 ) AMH ≥ 1.0 ng/ml Antral follicle count ( AFC ) ≥ 4 ≤ 15 follicle ( ovary ) Presence ovaries normal uterine cavity Informed consent Presence pregnancy Hypersensitivity follitropin alfa Ovarian cyst History ≥2 succeed ART cycle ( IVF and/or ICSI ) study cycle Previous history severe ovarian hyperstimulation syndrome Presence polycystic ovary ( PCO ) Presence endometriosis hydrosalpinx Presence uterine disorder History poor ( &lt; 4 oocyte ) hyper ( &gt; 25 oocyte ) responses FSH treatment dose 150 IU GnRHantagonist protocol Premature ovarian failure Ectopic pregnancy ( 3 month study cycle ) Presence clinically significant systemic disease Presence chronic cardiovascular , hepatic , renal pulmonary disease Presence endocrine disorder Neoplasia Male infertility without mobile spermatozoon ejaculate , need MESA/TESE/TESA Smoking &gt; 10 cigarettes/day Narcomania , alcoholism Planned PGS/PGD</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>vitro fertilization</keyword>
</DOC>